Track the 젠큐릭스 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 젠큐릭스 has recorded 49 insider filings. Market capitalisation: €35.7bn. The latest transaction was disclosed on 5 June 2026 (Purchase). Among the most active insiders: 조상래. All data is accessible without an account.
49
Insider Decl.
n/a
Thresholds
n/a
25 ops.
Buy Volume
n/a
5 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,366 of 27,906 companies
20.9
score / 100
Value
11
Quality
31
FCF yld-19%
Earn yld-21%
EV/EBITDA·
ROE-117%
Gross mgn79%
Net mgn-98%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.